137 related articles for article (PubMed ID: 3805379)
21. Incidence of non-melanoma skin cancer in patients treated with psoralen and ultraviolet A therapy.
Ortiz Salvador JM; Pérez-Ferriols A; Alegre de Miquel V; Saneleuterio Temporal M; Vilata Corell JJ
Med Clin (Barc); 2019 Jun; 152(12):488-492. PubMed ID: 30503067
[TBL] [Abstract][Full Text] [Related]
22. Skin carcinomas and treatment with photochemotherapy (PUVA).
Lindskov R
Acta Derm Venereol; 1983; 63(3):223-6. PubMed ID: 6192635
[TBL] [Abstract][Full Text] [Related]
23. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis.
Stern RS; Lunder EJ
Arch Dermatol; 1998 Dec; 134(12):1582-5. PubMed ID: 9875197
[TBL] [Abstract][Full Text] [Related]
24. Incidence of skin cancer in Japanese psoriatic patients treated with either methoxsalen phototherapy, Goeckerman regimen, or both therapies. A 10-year follow-up study.
Torinuki W; Tagami H
J Am Acad Dermatol; 1988 Jun; 18(6):1278-81. PubMed ID: 3385042
[TBL] [Abstract][Full Text] [Related]
25. Skin cancer in the PUVA-48 cooperative study.
Roenigk HH; Caro WA
J Am Acad Dermatol; 1981 Mar; 4(3):319-24. PubMed ID: 7217399
[TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up of skin cancer in the PUVA-48 cooperative study.
Forman AB; Roenigk HH; Caro WA; Magid ML
Arch Dermatol; 1989 Apr; 125(4):515-9. PubMed ID: 2649011
[TBL] [Abstract][Full Text] [Related]
27. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients.
Lim JL; Stern RS
J Invest Dermatol; 2005 Mar; 124(3):505-13. PubMed ID: 15737190
[TBL] [Abstract][Full Text] [Related]
28. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients.
Berne B; Fischer T; Michaëlsson G; Norén P
Photodermatol; 1984 Feb; 1(1):18-22. PubMed ID: 6531278
[TBL] [Abstract][Full Text] [Related]
29. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients.
Maier H; Schemper M; Ortel B; Binder M; Tanew A; Hönigsmann H
Dermatology; 1996; 193(3):185-91. PubMed ID: 8944338
[TBL] [Abstract][Full Text] [Related]
30. Skin tumors in the European PUVA study. Eight-year follow-up of 1643 patients treated with PUVA for psoriasis.
Morris RW
J Am Acad Dermatol; 1989 Feb; 20(2 Pt 1):297-8. PubMed ID: 2915070
[No Abstract] [Full Text] [Related]
31. The risk of melanoma in association with long-term exposure to PUVA.
Stern RS;
J Am Acad Dermatol; 2001 May; 44(5):755-61. PubMed ID: 11312420
[TBL] [Abstract][Full Text] [Related]
32. Risk of skin tumors in psoralen- and ultraviolet A-treated patients.
Henseler T; Christophers E
Natl Cancer Inst Monogr; 1984 Dec; 66():217-9. PubMed ID: 6531033
[TBL] [Abstract][Full Text] [Related]
33. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
Stern RS; Nichols KT; Väkevä LH
N Engl J Med; 1997 Apr; 336(15):1041-5. PubMed ID: 9091799
[TBL] [Abstract][Full Text] [Related]
34. Multiple squamous cell carcinomas in a psoriatic patient following high-dose photochemotherapy and cyclosporin treatment: response to long-term acitretin maintenance.
van de Kerkhof PC; de Rooij MJ
Br J Dermatol; 1997 Feb; 136(2):275-8. PubMed ID: 9068750
[TBL] [Abstract][Full Text] [Related]
35. Cancer incidence among Finnish patients with psoriasis treated with trioxsalen bath PUVA.
Hannuksela A; Pukkala E; Hannuksela M; Karvonen J
J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):685-9. PubMed ID: 8912561
[TBL] [Abstract][Full Text] [Related]
36. p53 immunoreactivity in cutaneous PUVA tumors is similar to that in other non-melanoma skin neoplasms.
Proby CM; du Peloux Menagé H; McGregor JM; Hobbs C; Norris PG; Smith N; Hawk JL; McKee PH
J Cutan Pathol; 1993 Oct; 20(5):435-41. PubMed ID: 8300928
[TBL] [Abstract][Full Text] [Related]
37. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis.
Seidl H; Kreimer-Erlacher H; Bäck B; Soyer HP; Höfler G; Kerl H; Wolf P
J Invest Dermatol; 2001 Aug; 117(2):365-70. PubMed ID: 11511317
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous and ocular side-effects of oral photochemotherapy: results of an 8-year follow-up study.
Cox NH; Jones SK; Downey DJ; Tuyp EJ; Jay JL; Moseley H; Mackie RM
Br J Dermatol; 1987 Feb; 116(2):145-52. PubMed ID: 3828211
[TBL] [Abstract][Full Text] [Related]
39. Skin cancers or premalignant lesions occur in half of high-dose PUVA patients.
Lever LR; Farr PM
Br J Dermatol; 1994 Aug; 131(2):215-9. PubMed ID: 7917985
[TBL] [Abstract][Full Text] [Related]
40. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients.
Katz KA; Marcil I; Stern RS
J Invest Dermatol; 2002 Jun; 118(6):1038-43. PubMed ID: 12060400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
